685 related articles for article (PubMed ID: 18434163)
21. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems.
Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M
Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anti-tumor evaluation of panaxadiol derivatives.
Liu XK; Ye BJ; Wu Y; Lin ZH; Zhao YQ; Piao HR
Eur J Med Chem; 2011 Jun; 46(6):1997-2002. PubMed ID: 21439693
[TBL] [Abstract][Full Text] [Related]
23. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
24. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
Gust R; Niebler K; Schönenberger H
J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of 5'-deoxy-4'-thio-L-nucleosides.
Cong L; Zhou W; Jin D; Wang J; Chen X
Chem Biol Drug Des; 2010 Jun; 75(6):619-27. PubMed ID: 20337785
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM
J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of C4-fluorinated solamins and their growth inhibitory activity against human cancer cell lines.
Kojima N; Hayashi H; Suzuki S; Tominaga H; Maezaki N; Tanaka T; Yamori T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6451-3. PubMed ID: 18993063
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis.
Kunz M; Driller KM; Hein M; Libnow S; Hohensee I; Ramer R; Hinz B; Berger A; Eberle J; Langer P
ChemMedChem; 2010 Apr; 5(4):534-9. PubMed ID: 20135670
[No Abstract] [Full Text] [Related]
30. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
32. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro.
Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M
Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373
[TBL] [Abstract][Full Text] [Related]
33. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
34. Selective antiproliferative activity of hydroxynaphthyl-beta-D-xylosides.
Jacobsson M; Ellervik U; Belting M; Mani K
J Med Chem; 2006 Mar; 49(6):1932-8. PubMed ID: 16539380
[TBL] [Abstract][Full Text] [Related]
35. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
36. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
Dullin A; Dufrasne F; Gelbcke M; Gust R
Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
[TBL] [Abstract][Full Text] [Related]
37. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
38. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
